Oxygen Therapy Market Overview:
Oxygen therapy is the use of oxygen as medical intervention to maintain enough oxygen in conditions such as hypoxia, hypoxemia, and other related conditions. Oxygen may be administered through a nasal cannula, face mask, or through hyperbaric oxygen chamber. This therapy helps maintain oxygen level in the blood for treatment of acute and chronic diseases such as chronic obstructive diseases (COPD), pneumonia, and asthma. Long-term therapy with oxygen is often useful in people suffering from COPD. Certain other acute or chronic disease conditions where oxygen therapy is effective include cystic fibrosis, dysplasia, heart failure, sleep apnea, and lung disorders.
Oxygen therapy market taxonomy
The global oxygen therapy market is segmented on basis of source equipment, application, delivery device, and end use. By type of source equipment, the oxygen therapy market is segmented into oxygen cylinders, liquid oxygen devices, and oxygen concentrators. On the basis of device type, the the oxygen therapy market is segmented into nasal cannula, face mask, bag valve mask, venturi mask, oxygen mask, non-rebreather mask, and CPAP devices. On the basis of application, the global oxygen therapy market is as asthma, cystic fibrosis, COPD, pneumonia, respiratory distress syndrome, and cardiovascular diseases.
Oxygen therapy is used in hospitals to cure patients suffering from respiratory diseases such as COPD and pneumonia, and also cardiovascular diseases fueling growth of the oxygen therapy market. Oxygen therapy is also used in clinics, rehabilitations centers and home care settings .
Increasing incidence of COPD and lung disorders drive growth of the oxygen therapy market across the globe
Factors such as high prevalence of respiratory related diseases, growing aging population, and increasing vulnerability of the populace to respiratory conditions are fueling growth of the oxygen therapy market in North America. According to the Center for Diseases Control and Prevention (CDC), around 15.7 million people in the U.S. were diagnosed with COPD in 2013. Other factors driving demand for oxygen therapy include innovation in portable oxygen concentrators, rise in number of untreated sleep apnea cases, favorable reimbursement scenario, growing demand for oxygen filling devices, good medical facilities, and high investment in research and development activities. The oxygen therapy market in Europe is also gaining traction in recent times, mainly fueled by increasing number of patients suffering from respiratory diseases and favorable government initiatives to facilitate respiratory care.
According to the World Health Organization, over 90% of COPD deaths occur in low income and middle income countries. Therefore, the oxygen therapy market is expected to grow substantially in African, Asian, and Latin American countries due to high prevalence of COPD and deaths due to the disease. Furthermore, increasing awareness among medical facilities, increasing government investment in healthcare facilities, and availability of low cost treatment is projected to drive demand for oxygen therapy in emerging economies.
Alarming increase in number of lung damage cases increasing demand for oxygen therapy for effective treatment
According to World Health Organization (WHO) over 3 million people die each year due to COPD. Increasing use of oxygen therapy in treatment of diseases such as COPD, asthma, obstructive sleep apnea, and respiratory distress syndrome is a supportive prevalent trend in the market. Long-term oxygen therapy for patients suffering from chronic lung disease can help improve quality and length of life, in turn creating a favorable environment for the market. Increasing risk of lung damage due to tobacco consumption, occupational hazards, and pollution would further augment market growth over the following decade.
Global players engaged in the oxygen therapy market
There are several medical device companies, both local player and global ones, engaged in manufacture of oxygen therapy devices. Some of the prominent players are Respironics, Inc. (a Philips company), Fisher & Paykel Healthcare Limited, Teleflex Incorporated, Invacare Corporation, AirSep Corporation, CareFusion Corporation, DeVilbiss Healthcare, MAQUET Holding B.V. & Co. KG, and ResMed, Inc.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Tel : +1-206-701-6702